Andrew J. Hirsh - Concepedia

Author

Andrew J. Hirsh

University of North Carolina at Chapel Hill

Also Known As

A. Hirsh, A. J. Hirsh, A.J Hirsh, A.J. Hirsh, Andrew Hirsh, Andrew J Hirsh, Andrew J. Hirsh, Boucher, Richard C., Ghio, Andrew J., Hirsh, Andrew J.

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill Parion Sciences (United States)University of Alberta

About

Andrew J. Hirsh is an author at University of North Carolina at Chapel Hill specializing in medicine, cell signaling, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	253
2	Cell Biology	2	2	236
3	Cellular Physiology	2	2	236
4	Immunology	2	2	236
5	Pharmacology	1	1	17

Andrew J. Hirsh

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
The CF Salt Controversy Robert Tarran, Barbara R. Grubb, David Parsons, Molecular Cell Cf Salt ControversyReporting StandardGlobal Challenge	2001	254
Regulation of the Epithelial Sodium Channel by Serine Proteases in Human Airways Scott H. Donaldson, Andrew J. Hirsh, Dong Chen Li, Journal of Biological Chemistry	2002	247
Ecto 5′-Nucleotidase and Nonspecific Alkaline Phosphatase Maryse Picher, Lauranell H. Burch, Andrew J. Hirsh, Journal of Biological Chemistry	2003	182
Cytokine Secretion by Cystic Fibrosis Airway Epithelial Cells Marie N. Becker, Mariam S. Sauer, Marianne S. Muhlebach, American Journal of Respiratory and Critical Care Medicine Cf CellsIl-6 SecretionLung InflammationImmunologyImmune Regulation	2003	135
Regulation of MUC5AC mucin secretion and airway surface liquid metabolism by IL-1β in human bronchial epithelia Thomas E. Gray, Ray D. Coakley, Andrew J. Hirsh, American Journal of Physiology-Lung Cellular and Molecular Physiology InflammationAsthmaTracheobronchitisInflammatory Lung DiseaseMucosal Immunology	2004	101
Evaluation of Second Generation Amiloride Analogs as Therapy for Cystic Fibrosis Lung Disease Andrew J. Hirsh, Juan Sabater, Andra Zamurs, Journal of Pharmacology and Experimental Therapeutics	2004	94
Pharmacological Properties of N-(3,5-Diamino-6-chloropyrazine-2-carbonyl)-N′-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine Methanesulfonate (552-02), a Novel Epithelial Sodium Channel Blocker with Potential Clinical Efficacy for Cystic Fibrosis Lung Disease Andrew J. Hirsh, Andra Zamurs, Jacquelyn Fleegle, Journal of Pharmacology and Experimental Therapeutics	2008	89
Design, Synthesis, and Structure−Activity Relationships of Novel 2-Substituted Pyrazinoylguanidine Epithelial Sodium Channel Blockers: Drugs for Cystic Fibrosis and Chronic Bronchitis Andrew J. Hirsh, Bruce F. Molino, Jianzhong Zhang, Journal of Medicinal Chemistry	2006	75
Cholecystokinin Decreases Intestinal Hexose Absorption by a Parallel Reduction in SGLT1 Abundance in the Brush-Border Membrane Andrew J. Hirsh, C. I. Cheeseman Journal of Biological Chemistry	1998	62
A <sub>2B</sub> Adenosine Receptors Regulate the Mucus Clearance Component of the Lung's Innate Defense System Brett Rollins, Mellisa Burn, Ray D. Coakley, American Journal of Respiratory Cell and Molecular Biology	2008	52

Page 1